Sanofi-Aventis U.S. LLC et al v. Amneal Pharmaceuticals LLC et al > Summary
Court Case Number 1:17-cv-00039
Filing Date Jan 12, 2017
Termination Date Oct 11, 2017
Court Delaware District Court
Status Dismissed - Settled
JudgesGregory M. Sleet
Plaintiff Attorneys
14Aventisub LLC
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Aventisub LLC
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Brandon J. Kennedy
Kennedy Law, PC
Sanofi
Attorney Name: Brandon J. Kennedy
Kennedy Law, PC
Aventisub LLC
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Defendant Attorneys
4AMNEAL PHARMACEUTICALS INDIA PRIVATE
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Amneal Pharmaceuticals
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Amneal Pharmaceuticals
Attorney Name: Samuel S. Park
Winston & Strawn
Amneal Pharmaceuticals
Attorney Name: Jovial Wong
Winston & Strawn
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Nov 17, 2015 |
| 08802735 | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | Aug 12, 2014 |
| 06794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 21, 2004 |
